Affini-T Therapeutics Company Profile, Contacts & Intelligence

Affini-T Therapeutics Overview

Affini-T is a leading clinical stage precision immunotherapy company targeting oncogenic driver mutations, beginning with KRAS, to develop potentially curative therapies for patients with solid tumors. We are advancing two distinct T Cell Receptor (TCR) based therapeutic modalities encompassing adoptive cellular therapies and bispecific T Cell Engagers, each designed to harness T cell immunity with unprecedented precision and potency against solid tumors. Our most advanced TCR T-cell therapies are built based on state-of-the-art engineering, synthetic biology, and gene editing proprietary platforms overcoming the challenges of addressing solid tumors. Our T Cell therapies have high specificity and the multi-faceted ability to strike and persist within the solid tumors. Building on the world-class innovation inherent in our leadership team, founders and differentiating technologies, we are powered to develop transformational medicines that last.

Headquarters

Watertown, Massachusetts, United States

Website

www.affinittx.com

Industry

Biotechnology Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Affini-T Therapeutics Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Affini-T Therapeutics People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Affini-T Therapeutics Workforce Composition

Seniority breakdown across 4 visible profiles.

Compare Similar Companies to Affini-T Therapeutics

Explore companies in related markets and compare their industry and employee estimates.